# OnCo record herthena-lung02 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/herthena-lung02/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "herthena-lung02", "NCT05338970" ;
  schema:name "HERTHENA-Lung02"@en ;
  schema:description "A HER3 ADC delayed progression by only a few days more than chemotherapy and did not extend survival, so its US application was withdrawn."@en ;
  schema:url <https://onco.cc/trials/herthena-lung02/> ;
  schema:dateModified "2026-09-06"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05338970>, <https://www.merck.com/news/patritumab-deruxtecan-biologics-license-application-for-patients-with-previously-treated-locally-advanced-or-metastatic-egfr-mutated-non-small-cell-lung-cancer-voluntarily-withdrawn/> ;
  onco:status "mixed" ;
  onco:phase "3" ;
  schema:startDate "2022-07-08" ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/egfr-mutant-nsclc/> ;
  onco:technologies <https://onco.cc/technologies/adc/> ;
  onco:targets <https://onco.cc/targets/her3/> ;
  onco:drugs <https://onco.cc/drugs/patritumab-deruxtecan/> ;
  onco:companies <https://onco.cc/companies/daiichi-sankyo/> ;
  onco:people <https://onco.cc/people/benjamin-besse/> .